Merck signs with Thermo Fisher

Article Excerpt

MERCK & CO. INC., $75.29, is a buy. The drugmaker (New York symbol MRK; TSINetwork Rating: Above Average) (www.merck.com; Shares o/s: 2.5 billion; Market cap: $186.2 billion; Dividend yield: 3.7%) has announced a deal with medical device maker Thermo Fisher Scientific (symbol TMO on New York) to manufacture its COVID-19 pill at Thermo Fisher’s site in Whitby, Ontario. Merck’s experimental COVID-19 medication helps prevent high-risk people early in the course of the disease from becoming seriously ill and dying. The site will manufacture the pill, molnupiravir, for distribution in Canada and the U.K. as well as markets in the European Union, Asia Pacific and Latin America. Merck & Co. is a buy. buy…